Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 101 clinical trials
Featured trial
Eczema (Atopic Dermatitis)

ITCHY OR SENSITIVE SKIN? Consider a clinical research study for eczema (atopic dermatitis).Insurance is not needed to participate in this study.

  • 72 views
  • 17 Nov, 2021
  • 1 location
Featured trial
Eczema Research Study

Looking for patients 18 years of age and older who have been diagnosed with eczema.  

  • 87 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Atopic Dermatitis

The OXFORAD™ Study will determine how well an investigational drug works in treating people with moderate-to-severe eczema (atopic dermatitis).  

  • 132 views
  • 23 Nov, 2020
  • 1 location
Featured trial
The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis.

The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis. 

  • 143 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Eczema / Atopic Dermatitis

Eczema / Atopic Dermatitis

  • 835 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Studies for the Treatment of Atopic Dermatitis (eczema)

Studies for the Treatment of Atopic Dermatitis (eczema)

  • 840 views
  • 08 Nov, 2020
  • 1 location
Featured trial
A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).

A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).

  • 570 views
  • 08 Nov, 2020
  • 1 location
Featured trial
Eczema Research Study - Compensation up to $420

  If you have symptoms of eczema such as itchy red patches you may qualify for a Research Study. Qualified participants receive study-related exams, medication and care from a board-certified dermatologist at no cost.  

  • 243 views
  • 23 Nov, 2020
  • 1 location
Featured trial
Study of Ruxolitinib Cream in Children With Atopic Dermatitis

Open-label, BID application to all affected areas identified at BSLN for 4 weeks (maximum use trial (MUsT) period). The next 4 weeks (treatment extension period) will be applied BID to active lesions only for the next 4 weeks for a total treatment period of 8 weeks. Eligible participants will be …

  • 0 views
  • 21 Mar, 2022
  • 16 locations
Featured trial
Integument-2 study

We are currently recruiting pediatric and adult patients with mild to moderate atopic dermatitis (eczema) for a study that investigates the safety and efficacy of the ARQ-151 cream.

  • 68 views
  • 07 Jul, 2022
  • 63 locations